| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| conestat alfa | complement c1r subcomponent | biotech | NA | drugbank | Angioedemas Hereditary[MeSHID:D054179] |
NA | approved,investigational | inhibitor |
| conestat alfa | complement c1s subcomponent | biotech | NA | drugbank | Angioedemas Hereditary[MeSHID:D054179] |
NA | approved,investigational | inhibitor |
| conestat alfa | coagulation factor xi | biotech | NA | drugbank | Angioedemas Hereditary[MeSHID:D054179] |
NA | approved,investigational | inhibitor |
| conestat alfa | coagulation factor xii | biotech | NA | drugbank | Angioedemas Hereditary[MeSHID:D054179] |
NA | approved,investigational | inhibitor |
| conestat alfa | prothrombin | biotech | NA | drugbank | Angioedemas Hereditary[MeSHID:D054179] |
NA | approved,investigational | inhibitor |
| conestat alfa | plasma kallikrein | biotech | NA | drugbank | Angioedemas Hereditary[MeSHID:D054179] |
NA | approved,investigational | inhibitor |
| conestat alfa | tissue-type plasminogen activator | biotech | NA | drugbank | Angioedemas Hereditary[MeSHID:D054179] |
NA | approved,investigational | inhibitor |
| click here to return to the previous page | ||||||||